First Time Loading...

AlzChem Group AG
XETRA:ACT

Watchlist Manager
AlzChem Group AG Logo
AlzChem Group AG
XETRA:ACT
Watchlist
Price: 43.8 EUR 1.15% Market Closed
Updated: May 17, 2024

AlzChem Group AG
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AlzChem Group AG
Cost of Revenue Peer Comparison

Comparables:
WCH
EVK
1COV
SY1
UZU

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
AlzChem Group AG
XETRA:ACT
Cost of Revenue
-€232.6m
CAGR 3-Years
-19%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Cost of Revenue
-€6.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Evonik Industries AG
XETRA:EVK
Cost of Revenue
-€11.2B
CAGR 3-Years
-8%
CAGR 5-Years
-4%
CAGR 10-Years
-2%
Covestro AG
XETRA:1COV
Cost of Revenue
-€11.9B
CAGR 3-Years
-13%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Cost of Revenue
-€3B
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Uzin Utz AG
XETRA:UZU
Cost of Revenue
-€342.1m
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
N/A

See Also

What is AlzChem Group AG's Cost of Revenue?
Cost of Revenue
-232.6m EUR

Based on the financial report for Dec 31, 2023, AlzChem Group AG's Cost of Revenue amounts to -232.6m EUR.

What is AlzChem Group AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-25%

Over the last year, the Cost of Revenue growth was 14%. The average annual Cost of Revenue growth rates for AlzChem Group AG have been -19% over the past three years , -25% over the past five years .